Clinical features of headache associated with mobile phone use: a cross-sectional study in university students by Chu, Min Kyung et al.
RESEARCH ARTICLE Open Access
Clinical features of headache associated with
mobile phone use: a cross-sectional study in
university students
Min Kyung Chu
1, Hoon Geun Song
2, Chulho Kim
1 and Byung Chul Lee
1*
Abstract
Background: Headache has been reported to be associated with mobile phone (MP) use in some individuals. The
causal relationship between headache associated with MP use (HAMP) and MP use is currently undetermined.
Identifying the clinical features of HAMP may help in clarifying the pathophysiology of HAMP and in managing
symptoms of individuals with HAMP. The aim of the present study is to describe the clinical features of HAMP.
Methods: A 14-item questionnaire investigating MP use and headache was administered to 247 medical students
at Hallym University, Korea. Individual telephone interviews were subsequently conducted with those participants
who reported HAMP more than 10 times during the last 1 year on the clinical features of HAMP. We defined
HAMP as a headache attack during MP use or within 1 hour after MP use.
Results: In total, 214 (86.6%) students completed and returned the questionnaire. Forty (18.9%) students
experienced HAMP more than 10 times during the last 1 year in the questionnaire survey. In subsequent
telephone interviews, 37 (97.4%) interviewed participants reported that HAMP was triggered by prolonged MP use.
HAMP was usually dull or pressing in quality (30 of 38, 79.0%), localised ipsilateral to the side of MP use (32 of 38,
84.2%), and associated with a burning sensation (24 of 38, 63.2%).
Conclusion: We found that HAMP usually showed stereotyped clinical features including mild intensity, a dull or
pressing quality, localisation ipsilateral to the side of MP use, provocation by prolonged MP use and often
accompanied by a burning sensation.
Background
The use of mobile phones (MPs) has increased dramati-
cally, with over 3 billion people currently using MPs
w o r l d w i d e[ 1 ] .I nK o r e a ,9 2 . 9 %o ft h ep o p u l a t i o no f
approximately 48.4 million people used MPs in 2008 [2].
With the increased use of MPs, some users have
reported the development of symptoms such as head-
ache, sleep disturbance, memory loss, dizziness, and
burning sensations during or after MP use [3,4]. Several
epidemiological studies have suggested that MP use may
be related to the occurrence of these symptoms [5].
Experiments aimed at explaining these symptoms have
shown changes in cerebral blood flow [6,7], altered elec-
troencephalogram (EEG) patterns [3,5,6], and changes in
responses to transcranial magnetic stimulation [8]
resulting from MP use. A series of double-blind, sham-
controlled studies have reported no significant differ-
ences in headache provocation between control and MP
radiofrequency fields (RFs) among participants who
experienced some of the aforementioned symptoms dur-
ing MP use [9-15]. Although these studies assessed pro-
vocation of headache by RFs similar to those generated
by MPs, the relationship between headache provocation
and real MP use is currently undetermined [16,17].
Recent proposals for standardised general diagnostic cri-
teria for the secondary headaches included typical head-
ache characteristics of the presumed causative factors in
addition to the temporal relationship of headache and
causative factors in onset, worsening and improvement
of headache [18]. Identifying the clinical features of
headache associated with mobile phone use (HAMP)
will help in understanding the pathophysiology of
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HAMP in addition to clarifying the relationship between
headache provocation and MP use.
Methods
This study was divided into 2 parts: an initial question-
naire survey and subsequent telephone interviews of
participants who reported that they experienced HAMP
more than 10 times during the last 1 year. HAMP was
defined as any headache during or within 1 hour after
MP use. In the initial questionnaire survey, participants
were asked about their MP use, current headaches not
associated with MP use (HNAMP) and HAMP. If a par-
ticipant reported HAMP more than 10 times during the
last 1 year, he or she was followed up by telephone
interview within 2 weeks of the initial questionnaire sur-
vey. The telephone interview was designed for a detailed
identification of HAMP (Figure 1). The study was con-
ducted in accordance with the guidelines of the Institu-
tional Review Board of Hallym University Sacred Heart
Hospital and with the principles in the Declaration of
Helsinki [19]. The authors had full access to all the data
in the study and take responsibility for the integrity of
the data and the accuracy of the data analysis. This
study was conducted in September 2005.
Subjects
We investigated the first-, second-, and third-year medi-
cal students at Hallym University College of Medicine in
Chuncheon, Korea. At the time of the initial question-
naire survey, we asked all participants for written signed
consent for participation and excluded those students
who: (1) declined to participate, (2) did not use MPs, or
(3) did not provide written consent for participation. An
investigator (CK) who was not involved in medical
student education at that time recruited participants and
collected signed consent forms.
Questionnaire survey
A 14-item questionnaire was administered to all partici-
pants. The questionnaire included 9 items concerning
characteristics of HNAMP such as frequency, duration,
quality, location and severity of headache; nausea;
vomiting; photophobia; and phonophobia (Additional
file 1). The questionnaire also included 3 items on the
current status of MP use (average daily duration, fre-
quency of MP use and overall duration of MP use) and
collected data on the participants’ gender and age. An
individual was defined as having HAMP if he or she
experienced HAMP more than 10 times during the last
1 year.
Telephone interview
A neurologist (MKC) conducted semi-structured tele-
phone interviews with respondents who reported that
they currently or previously experienced HAMP in the
questionnaire survey. The telephone interview included
18 questions on clinical features (onset time, frequency,
severity, quality, and location of headache), triggering
factors (prolonged MP use, frequent MP use, and other
triggering factors), and associated symptoms (burning
sensation, dizziness, nausea, vomiting, photophobia,
phonophobia, osmophobia and orbital or periorbital
pain) of HAMP (Additional file 2).
Statistical analysis
Categorical variables were summarised by the corre-
sponding percentages, and continuous variables were
generally summarised by descriptive statistics (mean and
standard deviation [SD]). Between-group differences
were evaluated using analysis of variance (ANOVA)
after confirming that the data were normally distributed.
R version 2.9.1 and R Commander version 1.4-10 statis-
tical software for Windows (GNU general public license)
were used for all analyses. The significance of each fac-
tor was analysed using 2-tailed p values, where p < 0.05
was considered statistically significant.
Results
Demographic features
A total of 247 medical students at Hallym University
College of Medicine were recruited, and 214 students
agreed to participate in the study. Two participants did
n o tu s eaM Pa tt h et i m eo ft h es u r v e ya n dw e r et h u s
excluded from the study. All of the remaining 212 parti-
cipants completed the questionnaire. Their mean age
was 23.6 ± 2.6 years; 84 participants (39.6%) were
women and 128 (60.4%) were men. In the questionnaire
survey, 40 participants indicated that they experienced
Figure 1 Study flow diagram.
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these, 38 participants completed the telephone interview
(Figure 1).
Mobile phone use
In the 212 participants, the mean daily duration of MP
use was 33.4 ± 34.5 minutes, and the mean daily fre-
quency of MP use was 7.4 ± 6.3 calls. The mean dura-
tion of MP use was 5.5 ± 4.0 years. No significant
differences in age, gender, daily duration of MP use,
daily frequency of MP use, or overall duration of MP
use were observed between participants who experi-
enced HAMP and those who did not (Table 1).
Headache not associated with mobile phone use
(HNAMP)
Among the 212 MP users who completed the question-
naire, 191 answered that they had experienced headache
in the previous year, and 135 reported that their
HNAMP lasted more than 30 minutes. Three partici-
pants with HAMP reported that they did not experience
HNAMP and only suffered HAMP during the previous
year. We observed no significant differences between
participants who experienced HAMP and those who did
not when analysing the following: prevalence of head-
aches lasting more than 30 minutes during the last 1
year, moderate or severe intensity of headache, pulsating
quality of headache, aggravation of headache by routine
physical activity, unilateral pain, nausea, and photopho-
bia. Phonophobia was more prevalent among partici-
pants with HAMP compared to participants without
HAMP. The proportion of participants identified in the
questionnaire survey as experiencing migraine according
to the ID-Migraine™ criteria [20] (experiencing at least
2 of the following conditions during headache: nausea,
photophobia, and functional impairment) was not signif-
icantly different between these 2 groups (Table 2).
Headache associated with mobile phone use (HAMP)
(1) Headache features of HAMP
Among the 212 MP users, 40 (18.9%) participants
reported in the questionnaire survey that they experi-
enced HAMP more than 10 times during the last 1 year.
Of the 40 participants with HAMP, 38 completed the
telephone follow-up interview.
A telephone interview was conducted to determine the
time of onset, frequency, location, characteristics, asso-
ciated symptoms, and triggering factors of HAMP. Eigh-
teen (47.4%) participants reported that their HAMP
developed during MP use, 11 (28.9%) reported that
HAMP developed after MP use, and 9 (23.7%) reported
that HAMP developed either during or after MP use.
Twenty (52.6%) participants reported that HAMP
occurred every time they used a MP (Figure 2). The
majority of participants reported that HAMP was dull
or pressing in quality, mild in intensity and localised to
the side of MP use (Figure 3-A, B, C). Four participants
reported aggravation of headache by physical activity.
(2) Associated symptoms of HAMP
During the telephone interview, 27 (71.1%) participants
with HAMP reported experiencing a burning sensation
every time they used a MP. In conjunction with HAMP,
15 (39.5%) participants reported dizziness and 12
(31.6%) reported orbital or periorbital pain (Table 3).
(3) Triggers of HAMP
Thirty-seven (97.4%) telephone-interviewed participants
claimed that prolonged MP use triggered HAMP. Three
(7.9%) participants reported that frequent use of MP
also triggered HAMP. The mean period of MP use
necessary to trigger HAMP was 49.7 ± 36.7 minutes,
and the median time was 40 minutes (Figure 4). One
participant with HAMP repo r t e dt h a th e a d a c h ea l s o
developed when using a regular telephone. When asked
whether the use of hands-free equipment during MP
calls affected HAMP, 16 participants reported that head-
ache did not develop when they used hands-free equip-
ments, and the remaining 22 participants had never
used hands-free equipments.
Discussion
The present study demonstrated that 18.9% of the parti-
cipants in the initial questionnaire survey experienced
HAMP more than 10 times during the last 1 year.
HAMP exhibited mostly stereotyped clinical features
such as mild intensity, localisation ipsilateral to the side
of MP use, dull or pressing quality, association with a
Table 1 Duration of daily mobile phone use, frequency of daily mobile phone use, and duration of mobile phone use
according to the HAMP status in questionnaire survey.
HAMP participants
(n = 40)
Non-HAMP participants
(n = 172)
p value
Age 23.88 ± 2.59 23.42 ± 3.14 NS
Female, N (%) 16 (40.0%) 105 (39.0%) NS
Duration of daily mobile phone use (minutes per day) 31.2 ± 31.4 34.0 ± 35.3 NS
Frequency of daily mobile phone use (number per day) 7.1 ± 5.7 7.4 ± 6.4 NS
Duration of mobile phone use (years) 6.6 ± 6.9 5.3 ± 2.8 NS
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use.
These results are similar to those of a study on MP
users in Sweden and Norway, in which 8.4-13% of MP
users reported HAMP [21]. In Saudi Arabia, HAMP was
observed in 22.4% of MP users [22]. Santini et al.
reported that 10-20% of MP users complained of
HAMP in a questionnaire study conducted in France
[23]. Discrepancies in the proportion of MP users who
experience HAMP may be due to differences in MP
types, demographic features of users, social level of con-
cerns about MP use or media reporting about them
[24]. In addition to headache, a burning sensation and
dizziness have been commonly observed among MP
users. Burning sensation and dizziness accompanying
headache were also frequently observed in our study.
Headache during or after MP use could be induced by
altering conditions during MP use including
radiofrequency fields (RFs), psychological factor, tem-
perature change, noise and various combinations
thereof.
Exposure to RFs during MP use has been suggested to
trigger a variety of symptoms such as headache, fatigue,
concentration difficulties, and nausea [11]. A series of
double-blind provocation studies failed to demonstrate a
causal relationship between RFs exposure and these
symptoms [9,10,12-15]. A meta-analysis of 46 blind or
double-blind provocation studies reported no robust evi-
dence in support of a connection between RFs exposure
and symptoms as a biological entity [17].
To date, no specific effects of active RFs exposure
have been identified, nor has any difference in triggering
symptoms been noted between active and sham condi-
tions. Instead, various responses have been observed in
repeated exposures of the same participants. Thus, these
provocation studies suggest the role of psychological
factor, a nocebo effect, in symptom provocation [25-27].
Nocebo effect refers to harmful, unpleasant, or undesir-
able effects a subject manifests after receiving a sham
treatment [26,28]. In the present study, we used an
initial questionnaire survey and subsequent telephone
interviews, and did not evaluate psychological factors or
nocebo effects associated with HAMP provocation.
Additional altering conditions on subjects during MP
use are local temperature change and noise [29], both of
which can provoke headache [30-33]. Local temperature
elevation in the area of MP use has been noted in
Table 2 Clinical features of headache not associated with mobile phone use (HNAMP).
HAMP participants
N (%)
Non-HAMP participants
N (%)
p value
Headache not associated with mobile phone use, lasing ≥ 30 min. 23 (57.5)* 112 (65.1)* NS
Moderate or severe intensity 13 (35.1)
† 51 (33.1)
† NS
Unilateral pain 19 (51.4)
† 68 (44.2)
† NS
Pulsating quality 14 (37.8)
† 52 (33.8)
† NS
Aggravation of headache by routine activity 9 (24.3)
† 24 (15.64)
† NS
Nausea 4 (10.8)
† 12 (7.8)
† NS
Photophobia 6 (16.2)
† 24 (15.6)
† NS
Phonophobia 28 (75.7)
† 72 (46.8)
† 0.002
ID-migraine (%) 4 (10.8)
† 13 (8.4)
† NS
NS: not significant. *From all participants at initial questionnaire survey (40 participants with HAMP and 172 participants without HAMP).
†From participants with
headache not associated with mobile phone use (37 HAMP participants and 154 Non-HAMP participants).
Figure 2 Frequency of HAMP during or after MP use. Figure 3 Quality (A), intensity (B) and location (C) of HAMP.
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same as an actual human voice and usually includes
noise [36]. One double-blind cross-over provocation
study has taken into account thermal effects of MP use
in a provocation test [11]. These investigators used a
heated (39 ± 0.2°C) ceramic plate to mimic the sensa-
tion caused by using a warm MP during active and
sham exposures of RFs. However, they did not investi-
gate whether temperature change during MP use
induced symptoms solely or in combination with RFs
exposure. The effects of local temperature change and
noise in connection with MP use in symptoms trigger-
ing by blinded tests were not reported yet. In our study,
a burning sensation was reported by 71.1% of partici-
pants with HAMP and phonophobia was more prevalent
among participants with HAMP compared to those
without HAMP. These findings suggest the possibility
that local temperature change and/or noise resulting
from MP use are associated with HAMP provocation.
Proposals for new standard general diagnostic criteria
for secondary headaches include suggestions in evidence
of causation of headache: (1) headache has occurred in
temporal relationship to the onset of the presumed cau-
sative disorder, (2) headache has occurred or has signifi-
cantly worsening of the presumed causative factors, (3)
headache has improved in temporal relation to
improvement of the presumed causative factors, (4)
headache has characteristics of typical of the causative
disorder, (5) other evidence of causation. Evidence of
causation of headache is inferred when at least 2 of the
aforementioned 5 conditions are met [18]. Regarding
the results of our study, HAMP satisfied: (1) temporal
relationship to onset of headache (experiencing HAMP
more than 10 times during or after MP use), (2) occur-
ring or worsening by worsening of the presumed factor
(more individuals experienced HAMP with longer dura-
tion of MP use), and (3) characteristics typical of the
causative disorder (stereotyped headache features and
associated symptoms).
Headache provocation by regular telephone use was
reported by only 1 participant with HAMP and HAMP
did not occur when using hands-free equipment in the
present study. Rare headache provocation by regular tel-
ephone use suggests that HAMP is related to certain
conditions that are specifict oM Pu s ea n dn o tt or e g u -
lar telephone use. The lack of HAMP occurrence when
using hands-free equipments also suggests that certain
factor(s) nullified by hands-free equipments are related
to HAMP provocation.
One possible mechanism for headache provocation by
regular telephone use was her chronic headache disor-
der. Her HNAMP occurred 4 days per week with
migrainous features (nausea, aggravation by routine phy-
sical activity and phonophobia). Clinical features of her
HNAMP suggested that she had chronic migraine
[37,38]. Her headache provocation by regular telephone
use probably resulted from enhanced sensitivity to
environmental stimuli in chronic migraine. The other
possible mechanism for her headache provocation by
regular telephone use is idiopathic environmental hyper-
sensitivity to electromagnetic fields (IEI-EMF) [17].
However, we did not assess the symptoms during or
after using electrical devices other than MP and regular
telephone and could not know whether she had IEI-
EMF.
Our study has some limitation s .F i r s t ,t h i ss t u d yw a s
not a blinded attempt to provoke headache under speci-
fic conditions. Instead, we have described the self-
reported prevalence and clinical features of HAMP
among MP users under actual conditions. Thus, we
were not able to evaluate the causal relationship
between headache provocation and specific factors
related to MP use. Second, the participants in this study
were all medical students in Korea. Most of them were
20-30 years of age and used MPs; therefore, our study
participants did not reflect the general population.
Third, the initial questionnaire survey assessed only the
occurrence of headache and HAMP, and we conducted
follow-up interviews with only those participants who
reported that they were currently experiencing or had
Table 3 Associated symptoms of HAMP in telephone
interview.
Associated symptoms No. of participants (%)
Burning sensation 27 (71.1)
Dizziness 15 (39.5)
Orbital or periorbital pain 12 (31.6)
Phonophobia 9 (23.7)
Nausea 4 (10.5)
Photophobia 1 (2.6)
Osmophobia 0 (0.0)
Figure 4 Time to onset of HAMP after starting MP use.
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associated symptoms such as burning sensation, dizzi-
ness, and orbital or periorbital pain during the telephone
interviews, but because they were not included in the
initial questionnaire survey, we were unable to indepen-
dently evaluate MP-associated symptoms other than
headache among MP users. Fourth, the study was con-
ducted in 2005 when only code division multiple access
(CDMA) type MPs were available in Korea. CDMA-type
MPs and global system for mobile communication
(GSM) type MPs differ in their operating frequency
range and electromagnetic filed output power. Thus, the
effects of CDMA-type MPs on humans may differ from
those of GSM-type MPs. Nevertheless, the prevalence of
HAMP among CDMA-type MP users in our study was
similar to those of previous reports of HAMP among
GSM-type MP users. Fifth, we screened for HAMP by
using an initial questionnaire survey in which the parti-
cipants were asked to recall HAMP during the last 1
year, and there is the possibility of erroneous memory
of their headaches. In the present study, most partici-
pants with HAMP reported their HAMP occurred fre-
quently during or after MP use (Figure 2). These
findings suggest that most participants with HAMP had
experienced HAMP recently and might have answered
positively in the initial questionnaire survey.
Conclusions
We conclude that HAMP usually presented with stereo-
typed clinical features such as mild intensity, a dull or
pressing quality, localisation ipsilateral to the side of MP
use, provocation by prolonged MP use and accompani-
ment by a burning sensation. Although earlier double-
blind RFs provocation tests failed to demonstrate a rela-
tionship between HAMP or MP-associated symptoms
and RFs exposure, further randomised, controlled pro-
vocation studies that examine the effects of altering con-
ditions by MP use including noise, local temperature
change, RFs exposure and combinations thereof, are
needed in order to better understand the development
and nature of HAMP.
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